A new gravitational-wave catalogue reports 161 additional black hole mergers, bringing the total to 390 detections.
Researchers warn Agentjacking can abuse Sentry errors to make AI coding agents run malicious code on developer machines.
The search for “alien” intelligences isn’t only looking to outer space: some biologists are convinced that weird and wonderful forms of intelligence already exist right here on earth, and that they hold the key to understanding intelligence itself. In the first of a two part series, Michael Levin tries to shake us out of any assumption that intelligent beings must be embodied in a conventional way. Instead, he suggests, patterns in a medium might be intelligent, and any distinction between thinkers and thoughts is in the eye of the beholder. Read part two of our series here.
SETI, the Search for Extraterrestrial Intelligence, is a scientific endeavor with two key things going for it. First, it would have obvious and enormous impacts on our world if it were to succeed. And second, regardless of whether any extraterrestrial intelligence is found, it’s fascinating in and of itself because it forces us to ask fundamental questions in science and philosophy:
What exactly are we looking for, and how do we know if we’ve found it?
For many people who suffer from depression, the condition is not just about feeling down but also about a loss of motivation and difficulty finding pleasure in activities they used to enjoy. A new study conducted in Sweden shows that a medicine used to treat Parkinson’s disease can be used as an add-on therapy to alleviate these symptoms in some patients with treatment-resistant depression. The study has been published in Nature Medicine.
The researchers at Lund University and the psychiatric services in Region Skåne have identified the potential new therapy for the condition associated with depression that involves a reduced ability to feel joy, pleasure or motivation—known as anhedonia. Those affected may lose interest in things that they previously found meaningful or rewarding.
The study is an example of what is known as drug repurposing, whereby an already approved medicine is used to treat a different condition. In this study, the researchers investigated pramipexole, which has long been used to treat Parkinson’s disease, as an add-on therapy for depression with marked anhedonia.
A popular over-the-counter supplement taken for joint pain might increase people’s risk for Alzheimer’s disease, a new study says.
Glucosamine use is associated with a 25% higher odds that a person will progress from mild cognitive impairment to dementia and Alzheimer’s disease, researchers report in the journal Nature Metabolism.
“While it’s an association and not proof of causality, it does raise an important clinical question that now deserves much more attention,” researcher Matt Gentry said in a news release. He’s chair of biochemistry and molecular biology at the University of Florida.
🔒 Make yourself and your family AI-scam proof, step by step → https://neuralnutshell.com.
The Nobel Prize-winner Geoffrey Hinton, computer scientist popularly called the \.